Further, PET studies have indicated the ability of [11C]CS1P1 to visualize S1PR1 expression in MS lesions, aligning with MRI-detected abnormalities, thereby highlighting the potential of [11C]CS1P1 PET to serve as a biomarker for disease progression 217-220. The gene discussed is S1PR1; the disease is myeloid sarcoma.